Publisher
Springer Science and Business Media LLC
Subject
Complementary and alternative medicine,General Medicine
Reference73 articles.
1. GLOBOCAN 2012 [Internet]. GLOBOCAN 2012. 2016 [citado 28 de junio de 2016]. Disponible en:
http://globocan.iarc.fr/Pages/fact_sheets_population.aspx
2. Sociedad Española de Oncología Médica (SEOM). Las Cifras del Cáncer en España 2016. Madrid: Sociedad Española de Oncología Médica (SEOM); 2016. p. 24.
3. Rodríguez San Felipe MJ, Aguilar Martínez A, Manuel-y-Keenoy B. Influence of body weight on the prognosis of breast cancer survivors; nutritional approach after diagnosis. Nutr Hosp diciembre de. 2013;28(6):1829–41.
4. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG), Dowsett M, Forbes JF, Bradley R, Ingle J, Aihara T, et al. Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. Lancet Lond Engl. 2015;386(10001):1341–52.
5. Crew KD, Greenlee H, Capodice J, Raptis G, Brafman L, Fuentes D, et al. Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2007;25(25):3877–83.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献